Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0123 Transporter Info | ||||
| Gene Name | SLC18A1 | ||||
| Protein Name | Vesicular amine transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs2270637 | ||||
| Site of GPD | chr8:20179316 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | C>G | ||||
| Minor Allele Frequency | G=0.1809/697 (Global) | ||||
| Allele G | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
| Reserpine | Drug Info | Neuropsychiatric Disorder | Correlated with the neuropsychiatric disorders (compare with C) | [ 1] | |
| Tetrabenazine | Drug Info | Neuropsychiatric Disorder | Correlated with the neuropsychiatric disorders (compare with C) | [ 1] | |
| Genetic Polymorphism | rs1390938 | ||||
| Site of GPD | chr8:20179202 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | A>G | ||||
| Minor Allele Frequency | A=0.1889/2457 (Global) | ||||
| Allele A | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
| Reserpine | Drug Info | Neuropsychiatric Disorder | Correlated with the neuropsychiatric disorders (compare with G) | [ 1] | |
| Tetrabenazine | Drug Info | Neuropsychiatric Disorder | Correlated with the neuropsychiatric disorders (compare with G) | [ 1] | |
| Genetic Polymorphism | rs2270641 | ||||
| Site of GPD | chr8:20180955 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | T>C / T>G | ||||
| Minor Allele Frequency | G=0.2462/1233 (Global) | ||||
| Allele G | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
| Reserpine | Drug Info | Neuropsychiatric Disorder | Correlated with the risk for schizophrenia (compare with T) | [ 1] | |
| Tetrabenazine | Drug Info | Neuropsychiatric Disorder | Correlated with the risk for schizophrenia (compare with T) | [ 1] | |
| References | |||||
| 1 | Genetic variants in the vesicular monoamine transporter 1 (VMAT1/SLC18A1) and neuropsychiatric disorders. Methods Mol Biol. 2010;637:165-80. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.